Clinical trial

Intrathecal Amniotic Fluid Stem Cells for Progressive Multiple Sclerosis

NCT06841068

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2026-02-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2026-02-01Date precision: month

Registry last updated2026-02-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Progressiveunresolved

Interventions

Amniotic fluid or placental CD117 stem cellsBIOLOGICAL

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

Mapped research locations

CharlotteNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06841068 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.